A Phase II Study of Paclitaxel and Carboplatin with a Biweekly Schedule in Patients with Epithelial Ovarian Cancer: Gynecologic Cancer Network Trial.

Conclusion: Paclitaxel combined with carboplatin using a biweekly schedule is a safe and effective chemotherapy regimen for patients with epithelial ovarian cancer. Our results suggest that a biweekly schedule is well tolerated and is less toxic than a triweekly schedule.
PMID: 24614392 [PubMed - in process]

Source: Journal of Nippon Medical School - March 15, 2014 Category: Universities & Medical Training Authors: Yoneyama K, Konishi H, Yahata T, Fujita K, Aoki Y, Doi D, Matsushima T, Kodama S, Honma S, Kato H, Nakayama H, Kamoi S, Asakura H, Takeshita T, Tanaka K Tags: J Nippon Med Sch Source Type: research